• TH
    • EN
    • Register
    • Login
    • Forgot Password
    • Help
    • Contact
  • Register
  • Login
  • Forgot Password
  • Help
  • Contact
  • EN 
    • TH
    • EN
View Item 
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Articles
  • View Item
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

A review of drug pricing control system in Thailand

อรอนงค์ วลีขจรเลิศ; ธนนรรจ์ รัตนโชติพานิช; พรพิศ ศิลขวุธท์; ธนภร ชัยจิต; ขวัญสุดา ชาติโสม; จุฬาภรณ์ ลิมวัฒนานนท์; On-anong Waleekhachonloet; Thananan Rattanachotphanit; Pornpit Silkavute; Thanaporn Chaijit; Kwansuda Chadsom; Chulaporn Limwattananon;
Date: 2555-06
Abstract
This study focused on a review of the national system for drug price policy. Methods including interviewing key persons in various organizations, meetings with experts, studying related documents and literatures, were used. The study revealed that Ministry of Public Health (MOPH hospitals) had several indirect drug price control mechanisms for government sector especially for the MOPH hospitals themselves. Drug price control has been started in the process of national essential drug list (ED) selection. Cost effectiveness and budget impact analyses were parts of the consideration criteria. After drugs were selected as the ED, median price would be set as the price control measure for procurement process of MOPH hospitals. In addition, central negotiation was used for controlling price of single source nonessential drugs in MOPH hospitals. National Health Security Office takes the leading role in price negotiating of high cost ED to ensure accessibility for their beneficiaries. However, limited items were negotiated in each year. Group purchasing in level of provinces and regions was not much expanded from the past. There exists no autonomous body and no regulation for controlling of manufacturer price setting before drug registration processes. No regulation and system for controlling mark up in private sector have been implemented. Selling price was controlled to not more than price list. For drug price monitoring, only voluntary reporting of MOPH hospital purchasing price was available under the Drug and Medical Supply Information Center (DMSIC). As the ways to improve drug price control system in Thailand, manufacturer production cost structure should be submitted as the condition for national essential drug list consideration. In terms of negotiation, knowledge management of negotiation and purchasing strategies, expanding of items for central negotiation for all three health insurance schemes are encouraged. Drug price setting for procurement and a monitoring system should be improved. Moreover, a study on adverse effects of drug price control system on domestic pharmaceutical industries is necessary.
Copyright ผลงานวิชาการเหล่านี้เป็นลิขสิทธิ์ของสถาบันวิจัยระบบสาธารณสุข หากมีการนำไปใช้อ้างอิง โปรดอ้างถึงสถาบันวิจัยระบบสาธารณสุข ในฐานะเจ้าของลิขสิทธิ์ตามพระราชบัญญัติสงวนลิขสิทธิ์สำหรับการนำงานวิจัยไปใช้ประโยชน์ในเชิงพาณิชย์
Fulltext
Thumbnail
Name: hsri-journal-v6n2 ...
Size: 260.8Kb
Format: PDF
Download

User Manual
(* In case of download problems)

Total downloads:
Today: 0
This month: 1
This budget year: 124
This year: 62
All: 1,896
 

 
 


 
 
Show full item record
Collections
  • Articles [1366]

    บทความวิชาการ


DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

HSRI Knowledge BankDashboardCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjectsSubjectsการบริการสุขภาพ (Health Service Delivery) [619]กำลังคนด้านสุขภาพ (Health Workforce) [99]ระบบสารสนเทศด้านสุขภาพ (Health Information Systems) [286]ผลิตภัณฑ์ วัคซีน และเทคโนโลยีทางการแพทย์ (Medical Products, Vaccines and Technologies) [125]ระบบการเงินการคลังด้านสุขภาพ (Health Systems Financing) [158]ภาวะผู้นำและการอภิบาล (Leadership and Governance) [1281]ปัจจัยสังคมกำหนดสุขภาพ (Social Determinants of Health: SDH) [228]วิจัยระบบสุขภาพ (Health System Research) [28]ระบบวิจัยสุขภาพ (Health Research System) [20]

DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV